You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission
  1. Mathias Lichterfeld1,
  2. Eric S Rosenberg2
  1. 1Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
  2. 2Department of Medicine and Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA
  1. Correspondence to Eric S Rosenberg
    Department of Medicine and Pathology, Massachusetts General Hospital, Gray J-504, 55 Fruit Street, Boston, MA 02114, USA; erosenberg1{at}partners.org

https://doi.org/10.1136/ebmed.2011.100278

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505.OpenUrlCrossRefPubMedWeb of Science

    Context

    The reduction of HIV-1 transmission remains one of the highest global health priorities. The use of established antiretroviral drugs for preventing HIV-1 transmission was first considered in 1994, after an observational clinical study showed reduced HIV-1 infection rates in partners of HIV-1 infected persons treated with zidovudine monotherapy.1 In 2007, the HIV Prevention Trials Network (HPTN) initiated a randomised-controlled clinical trial (HPTN 052) in which the effect of antiretroviral combination therapy on heterosexual transmission of HIV-1 was evaluated; the results have recently been reported.

    Methods

    HPTN 052 is a phase III, randomised-controlled clinical trial designed to determine if early initiation of antiretroviral therapy could reduce transmission of HIV-1 in …

    View Full Text

    Footnotes

    • Competing interests None.